Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy

| February 13, 2017 | 0 Comments
Early-Stage Cancer Trials Support Promise of Precision Medicine, Immunotherapy

Encouraging findings from several early-stage clinical trials featured at the 2016 American Society of Clinical Oncology annual meeting support the promise of precision medicine and immunotherapy.
See Original Article

Pembrolizumab Shows Promise in Patients with Rare Form of Skin Cancer

In a small clinical trial, more than half of the patients with an aggressive form of skin cancer called Merkel cell carcinoma responded to the immunotherapy drug pembrolizumab.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply